Synthesis of 5-chloro-N-aryl-1H-indole-2-carboxamide derivatives as inhibitors of human liver glycogen phosphorylase a.
Onda, K., Suzuki, T., Shiraki, R., Yonetoku, Y., Negoro, K., Momose, K., Katayama, N., Orita, M., Yamaguchi, T., Ohta, M., Tsukamoto, S.(2008) Bioorg Med Chem 16: 5452-5464
- PubMed: 18434170 
- DOI: https://doi.org/10.1016/j.bmc.2008.04.010
- Primary Citation of Related Structures:  
2ZB2 - PubMed Abstract: 
A series of 5-chloro-N-aryl-1H-indole-2-carboxamide derivatives were prepared and evaluated as inhibitors of human liver glycogen phosphorylase a (hLGPa). One compound, 5-chloro-N-[4-(1,2-dihydroxyethyl)phenyl]-1H-indole-2-carboxamide (2f), inhibited hLGPa with an IC(50) of 0.90microM. The pyridine analogue of 2f showed inhibitory activity of glucagon-induced glucose output in cultured primary hepatocytes with an IC(50) of 0.62microM and oral hypoglycemic activity in diabetic db/db mice. Crystallographic determination of the complex of 2f with hLGPa showed binding of the inhibitor in a solvent cavity at the dimer interface, with the two hydroxyl groups making favorable electrostatic interactions with hLGPa.
Organizational Affiliation: 
Drug Discovery Research, Astellas Pharma Inc., 5-2-3 Toukoudai, Tsukuba, Ibaraki 300-2698, Japan. [email protected]